Literature DB >> 30973371

Uterine Papillary Serous Carcinoma Arising in a Polyp: A Multicenter Retrospective Analysis on 75 Patients.

Vincenzo D Mandato1, Federica Torricelli2, Stefano Palomba1, Stefano Uccella3,4, Debora Pirillo1, Gino Ciarlini5, Pierandrea De Iaco6, Emilio Lucia7, Giorgio Giorda7, Antonino Ditto8, Fabio Ghezzi3, Francesca Sanseverino9, Massimo Franchi10, Giuseppe Bifulco11, Valentina Mastrofilippo5, Martino Abrate5, Lorenzo Aguzzoli5, Giovanni B La Sala1.   

Abstract

OBJECTIVES: The objectives of this study were to evaluate whether the international recommendations on the management of uterine papillary serous carcinoma arising in a polyp are uniformly followed in Italian Oncologic Centers and whether the strategy adopted is effective.
MATERIALS AND METHODS: Patients with uterine papillary serous carcinoma arising in a polyp and who had undergone a hysterectomy were identified in the 2003-2013 database of 7 Italian Gynecologic Oncology Centers. Clinical and pathologic characteristics and outcomes were compared between staging procedure types. Survival curves of the women were plotted using the Kaplan-Meier method and analyzed using Cox regression hazard model and the log-rank test. Associations between clinical parameters and the incidence of recurrence were assessed by generalized linear models and the Fisher test.
RESULTS: A total of 75 patients met the inclusion criteria. Recurrence-free survival was affected positively by type of surgical staging and negatively by preoperative diagnosis of hypertension. The association between surgical staging and recurrence-free survival resulted significant at univariate survival analysis (P=0.048 and 0.045) and maintained a trend of significance (P=0.070) in multivariate analysis, whereas hypertension was demonstrated to be the principal influencing factor.
CONCLUSIONS: The international recommendations on the management of uterine papillary serous carcinoma are not uniformly followed in daily practice, although the extension of the surgery seems to be associated with lower recurrence rates also when uterine papillary serous carcinoma is confined to a polyp or endometrial surface.

Entities:  

Mesh:

Year:  2019        PMID: 30973371     DOI: 10.1097/COC.0000000000000541

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  5 in total

1.  Combined Adjuvant Chemotherapy and Radiation Therapy Improves Disease-Free Survival for Uterine Serous Cancer.

Authors:  Jessica D Arden; Kimberly Marvin; Hong Ye; Lena Juratli; Sirisha R Nandalur; Zaid Al-Wahab; Jayson Field; Jill Gadzinski; Joseph Anthony Rakowski; Barry Rosen; Maha Saada Jawad
Journal:  Adv Radiat Oncol       Date:  2020-10-24

Review 2.  Should Endometrial Cancer Treatment Be Centralized?

Authors:  Vincenzo Dario Mandato; Andrea Palicelli; Federica Torricelli; Valentina Mastrofilippo; Chiara Leone; Vittoria Dicarlo; Alessandro Tafuni; Giacomo Santandrea; Gianluca Annunziata; Matteo Generali; Debora Pirillo; Gino Ciarlini; Lorenzo Aguzzoli
Journal:  Biology (Basel)       Date:  2022-05-18

Review 3.  The Many Faces of Serous Neoplasms and Related Lesions of the Female Pelvis: A Review.

Authors:  Sameera Rashid; Maria A Arafah; Mohammed Akhtar
Journal:  Adv Anat Pathol       Date:  2022-05-01       Impact factor: 3.875

Review 4.  Pathogenesis and Clinical Management of Uterine Serous Carcinoma.

Authors:  Li Zhang; Suet Ying Kwan; Kwong Kwok Wong; Pamela T Solaman; Karen H Lu; Samuel C Mok
Journal:  Cancers (Basel)       Date:  2020-03-14       Impact factor: 6.639

5.  Distant recurrence in a patient with polyp-confined stage IA serous endometrial carcinoma treated with adjuvant chemotherapy: A case report and review of literature.

Authors:  Annalyn Welp; Sarah Temkin; Stephanie Sullivan
Journal:  Gynecol Oncol Rep       Date:  2019-11-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.